Our results showed CCi to lowerFPG

Our results showed CCi to lower
FPG and lipid parameters dose dependently (p < 0.05) while raising the plasma HDL-c level (p < 0.05) in same dose-related fashion but with no
effect on plasma triglycerides level (p > 0.05). Results of acute oral toxicity showed CCi to be of low toxicity and as such could be considered
relatively safe on acute exposure. Thus, confirming its folkloric use and safety in suspected Type 2 diabetic patients.
plasma triglycerides level
but with no
effect on plasma triglycerides level
in same dose-related fashion but with no effect on plasma triglycerides level

ผลลัพธ์ (อังกฤษ) 2:

Our results showed CCI to Lower
FPG and lipid Parameters dose dependently (P <.05) while Raising The Level Plasma HDL-C (P <twelve five a.m.) in dose-Related Fashion Same but with no
Effect on Plasma Triglycerides Level (P> 00:05). Results of acute oral toxicity showed to be of CCI Such As Low toxicity and could be considered
relatively Safe on acute Exposure. Thus, confirm ITS folkloric Use and safety in Type 2 Diabetic patients suspected.
Plasma Triglycerides Level
but with no
Effect on Plasma Triglycerides Level
in Fashion Same but with no dose-Related Effect on Plasma Triglycerides Level.

ผลลัพธ์ (อังกฤษ) 3:

Our results showed CCi to lower
FPG and lipid parameters dose dependently (P < 0.05) while raising the plasma HDL-c level. (P < 0.05) in same dose-related fashion but with no
effect on plasma triglycerides level (P > 0.05). Results of acute oral. Toxicity showed CCi to be of low toxicity and as such could be considered
relatively safe on acute, Thus exposure.Confirming its folkloric use and safety in suspected Type 2 diabetic patients.

plasma triglycerides level but with no
effect. On plasma triglycerides level
in same dose-related fashion but with no effect on plasma triglycerides level.